Mikhail Blagosklonny, a popular name among the scientists and scholars who specialize in oncology and anti-aging medicine. He is considered as one of the leading authors, editors and scholarly contributors in the field of cancer and aging. He has published some papers and articles on these two subjects, and he is editor in chief in some renowned journals on wikipedia.org. An Alma mater of the First Pavlov State Medical University of St. Peterburg, he is also serving as a Professor of Oncology at Roswell Park Cancer Institute in New York.
Blagosklonny has an M.D. (Doctor of Medicine) Degree in Internal Medicine from First Pavlov State Medical University of St. Peterburg. From the same University, he earned his Ph.D. in Experimental Medicine and Cardiology. After completing his studies, he got the position of Associate Professor of Medicine at New York Medical College in 2002. Later on, Mikhail Blagosklonny became a Senior Scientist at Ordway Research Institute in Albany, New York where he worked till 2009. After this, he joined Roswell Park Cancer Institute in 2009 as a Professor of Oncology. Blagosklonny is now continuing his research on cancer and aging in this institute. He also has an interest in targeted cancer therapies which can protect normal cells and basic mechanisms of aging and anti-aging drugs on tandfonline.com.
In addition to research, Blagosklonny has been actively involved in publications as well. Mikhail Blagosklonny is the editor in chief of some renowned journals which includes Oncotarget, Aging, and Cell Cycle. He is also the Associate Editor of Cancer Biology & Therapy. Also, he has been a member of the editorial board of Cell Death & Differentiation for last six years.
Blagosklonny is highly acclaimed for his research and publication. His hypothesis about role of TOR signaling in cancer and aging has developed massive interest and further research in associated fields. He is now working on finding out the causes of aging and the factors which affect this process. Also, he is also working on finding out a cure for cancer at https://www.linkedin.com/in/mikhail-blagosklonny-91abb531. He has also proposed the usage of Rapamycin, a popular cancer drug as a possible solution for life extension or simply delay aging process. He has been passionately advocating for Rapamycin in longevity research.
Blagosklonny has made very remarkable progress with his research findings, and he has plans to initiate research in a larger scale in his interest areas, i.e. cancer and aging. He is confident that one day we will be able to come up with a cure for cancer and aging.